DR HEMRAJ NANDANWAR

Dr. DR HEMRAJ NANDANWAR

CSIR-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh INDIA
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2022 in ACS Infectious Diseases
Verified
Journal Article
Open access
RTRushikesh Tambat
Rushikesh Tambat
NMNisha Mahey
Nisha Mahey
NCNishtha Chandal
Nishtha Chandal
DVDipesh Kumar Verma
Dipesh Kumar Verma
MJManoj Jangra
Manoj Jangra
DR HEMRAJ NANDANWARDR HEMRAJ NANDANWAR
DR HEMRAJ NANDANWAR
The use of efflux pump inhibitors (EPIs) as potentiators along with the traditional antibiotics assists in the warfare against antibiotic-resistant superbugs. Efflux pumps of the resistance-nodulation-cell division (RND) family play crucial roles in multidrug resistance in Escherichia coli and Pseudomonas aeruginosa. Despite several efforts, clinically useful inhibitors are not available at present. This study describes ethyl 4-bromopyrrole-2-carboxylate (RP1) isolation, an inhibitor of RND transporters from the library of 4000 microbial exudates. RP1 acts synergistically with antibiotics by reducing their minimum inhibitory concentration in strains overexpressing archetype RND transporters (AcrAB-TolC and MexAB-OprM). It also improves the accumulation of Hoechst 33342 and inhibits its efflux (a hallmark of EPI functionality). The antibiotic-RP1 combinations prolong the postantibiotic effects and reduce the mutation prevention concentration of antibiotics. Additionally, from Biolayer Interferometry spectra, it appears that RP1 is bound to AcrB. RP1 displays low mammalian cytotoxicity, no Ca2+ channel inhibitory effects, and reduces the intracellular invasion of E. coli and P. aeruginosa in macrophages. Furthermore, the RP1-levofloxacin combination is nontoxic, well-tolerated, and notably effective in a murine lung infection model. In sum, RP1 is a potent EPI and worthy of further consideration as a potentiator to improve the effectiveness of existing antibiotics.

1 October 2019 in Microbial Drug Resistance
Verified
Journal Article
Open access
NMNavdezda Maurya
Navdezda Maurya
MJManoj Jangra
Manoj Jangra
RTRushikesh Tambat
Rushikesh Tambat
DR HEMRAJ NANDANWARDR HEMRAJ NANDANWAR
DR HEMRAJ NANDANWAR
Nosocomial infections caused by Klebsiella pneumoniae are primarily characterized by a high prevalence of extended-spectrum β-lactamases (ESBL's) and a soaring pace of carbapenemase dissemination. Availability of limited antimicrobial agents as a therapeutic option for multidrug-resistant bacteria raises an alarming concern. This study aimed at the molecular characterization of multidrug-resistant K. pneumoniae clinical isolates and studied the role of efflux pumps in β-lactam resistance. Thirty-three isolates confirmed as ESBL-positive K. pneumoniae that harbored resistance genes to major classes of antibiotics. The results showed that CTX-M15 was the preeminent β-lactamase along with carbapenemases in ESBL-positive isolates. However, the efficacy of different antibiotics varied in the presence of lactamase inhibitors and efflux pump inhibitors (EPIs). Those showing increased efficacy of antibiotics with EPI were further explored for the expression of efflux pump genes and expressed a significantly different level of efflux pumps. We found that an isolate had higher expression of kpnF (SMR family) and kdeA (MATE family) pump genes relative to RND family pump genes. No mutations were observed in the genes for porins. Together, the findings suggest that β-lactamases are not the only single factor responsible for providing resistance against the existing β-lactam drugs. Resistance may increase many folds by simultaneous expression of RND family (the most prominent family in Gram-negative bacteria) and other efflux pump family.

1 June 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
MJManoj Jangra
Manoj Jangra
MKManpreet Kaur
Manpreet Kaur
RTRushikesh Tambat
Rushikesh Tambat
RRRohit Rana
Rohit Rana
SMSushil K. Maurya
Sushil K. Maurya
DR HEMRAJ NANDANWARDR HEMRAJ NANDANWAR
DR HEMRAJ NANDANWAR
The World Health Organization has categorized the Gram-negative superbugs, which are inherently impervious to many antibiotics, as critical priority pathogens due to the lack of effective treatments. The breach in our last-resort antibiotic (i.e., colistin) by extensively drug-resistant and pan-drug-resistant Enterobacteriaceae strains demands the immediate development of new therapies.

22 December 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
NMNisha Mahey
Nisha Mahey
RTRushikesh Tambat
Rushikesh Tambat
NCNishtha Chandal
Nishtha Chandal
DVDipesh Kumar Verma
Dipesh Kumar Verma
KTKrishan Gopal Thakur
Krishan Gopal Thakur
DR HEMRAJ NANDANWARDR HEMRAJ NANDANWAR
DR HEMRAJ NANDANWAR
Staphylococcus aureus is a frequent pathogen bacterium and the predominant cause of worsened nosocomial infections. Efflux pumps contribute to drug efflux and are reportedly associated with biofilm formation, thereby promoting difficult-to-treat biofilm-associated S. aureus infections.

1 May 2016 in Biologia
Verified
Journal Article
Closed access
PDF file
HRHarmandeep K. Randhawa
Harmandeep K. Randhawa
KHKanwarpreet K. Hundal
Kanwarpreet K. Hundal
PAPallavi N. Ahirrao
Pallavi N. Ahirrao
SJSanjay M. Jachak
Sanjay M. Jachak
DR HEMRAJ NANDANWARDR HEMRAJ NANDANWAR
DR HEMRAJ NANDANWAR

1 October 2012 in Fitoterapia
Verified
Journal Article
Closed access
Somendu RoySomendu Roy
Somendu Roy
SPSonika Pahwa
Sonika Pahwa
DR HEMRAJ NANDANWARDR HEMRAJ NANDANWAR
DR HEMRAJ NANDANWAR
SJSanjay Jachak
Sanjay Jachak